Zera Health vs PlushCare
A rate stated to hold against one that covers the starting dose only.
Zera Health
Editorial
$129/mo
Zera Health advertises compounded semaglutide at $129 a month, described by the seller as a low-dose weekly injection, with a daily dissolving tablet at $169 and compounded tirzepatide at $199. The rates are stated as flat across doses. All fifty states are served.
Pick it for: Readers who want the figure fixed across the ladder
PlushCare
Editorial
$149/mo
PlushCare advertises compounded semaglutide at $149 a month cash-pay, and states that the figure buys the 0.25 mg starting dose only, with every maintenance dose priced higher. Compounded tirzepatide is $399. Insurance is accepted on a separate basis from either figure.
Pick it for: Readers who want the brand and will price escalation separately
Our verdict
Zera Health states its rates hold at every dose. PlushCare's $149 is the starting-dose figure. The gap at month one is twenty dollars; past that, only one seller has committed to anything.
What actually separates them
Zera Health and PlushCare state different things about published price. Everything else they publish, they publish the same way.
PlushCare costs $20 more than Zera Health — 16% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,548 at Zera Health against $1,788 at PlushCare — a difference of $240.
| Zera Health | PlushCare | |
|---|---|---|
| Published price | $129/mo | $149/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.